AGO2 and neoplasm: The oncogenic function of AGO2 was documented in hypopharyngeal cancer where knock down of AGO2 led to the inhibition of cell growth and tumor formation in mice, as well as activation of the mitogenic FAK/PI3K/AKT pathway [26].